Vitamin D deficiency and dysfunctional adipose tissue are involved in the development of cardiometabolic disturbances (eg, hypertension, insulin resistance, type 2 diabetes mellitus, obesity, and dyslipidemia). We evaluated the relation between vitamin D and adipocytokines derived from adipose tissue. We studied 50 obese individuals who were classified into different subgroups according to medians of observed anthropometric parameters (body mass index, body fat percentage, waist circumference, and trunk fat mass). There was a negative correlation between vitamin D level and leptin and resistin (r = −.61, P < .01), while a positive association with adiponectin concentrations was found (r = .7, P < .001). Trend estimation showed that increase in vitamin D level is accompanied by intensive increase in adiponectin concentrations (growth coefficient: 12.13). In conclusion, a positive trend was established between vitamin D and the protective adipocytokine adiponectin. The clinical relevance of this relationship needs to be investigated in larger studies.
MustAStraussRS. Risks and consequences of childhood and adolescent obesity. Int J Obes Relat Metab Disord. 1999;23
(suppl 2):S2–S11.
2.
Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. National institutes of health. Obes Res. 1998;6(suppl 2):51S–209S.
Tomić-NaglićD SESrdićBRadovanovT. Masno tkivo kao endokrina žlezda. Medicina Danas. 2008;7
(4-6):142–147.
5.
MurdoloGSmithU. The dysregulated adipose tissue: a connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis. Nutr Metab Cardiovasc Dis. 2006;16
(suppl 1):S35–S38.
6.
KershawEEFlierJS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89
(6):2548–2556.
7.
AquilanteCLKosmiskiLAKnutsenSDZinehI. Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults. Metabolism. 2008;57
(4):494–501.
8.
OhmoriRMomiyamaYKatoR. Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J Am Coll Cardiol. 2005;46
(2):379–380.
9.
KatsikiNAthyrosVGKaragiannisAMikhailidisDP. Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview [published online April 25, 2013]. Curr Vasc Pharmacol. 2013.
10.
KoernerAKratzschJKiessW. Adipocytokines: leptin—the classical, resistin—the controversial, adiponectin—the promising, and more to come. Best Pract Res Clin Endocrinol Metab. 2005;19
(4):525–546.
11.
MisraAVikramNK. Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. Nutrition. 2003;19
(5):457–466.
12.
StokićESrdić GalićBTomić-NaglićDIsenovićE. Sagittal abdominal diameter (SAD) in identification obese patients of higher cardiovascular risk. Cardiology. 2013;126:169.
13.
Bischoff-FerrariHAGiovannucciEWillettWCDietrichTDawson-HughesB. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84
(1):18–28.
14.
VanlintS. Vitamin D and obesity. Nutrients. 2013;5
(3):949–956.
15.
ChiuKCChuAGoVLSaadMF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79
(5):820–825.
16.
ScraggRSowersMBellC. Third National H, nutrition examination S. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the third national health and nutrition examination survey. Diabetes Care. 2004;27
(12):2813–2818.
17.
AndersonJLMayHTHorneBD. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol. 2010;106
(7):963–968.
18.
EarthmanCPBeckmanLMMasodkarKSibleySD. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int J Obes (Lond). 2012;36
(3):387–396.
19.
StokicEKupusinacATomic-NaglicD. Obesity and vitamin D deficiency: trends to promote a more proatherogenic cardiometabolic risk profile. Angiology. 2015;66
(3):237–243.
20.
NeedAGO’LoughlinPDHorowitzMNordinBE. Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin Endocrinol (Oxf). 2005;62
(6):738–741.
21.
VilarrasaNVendrellJMaravallJ. Is plasma 25(OH)D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population?Endocrine. 2010;38
(2):235–242.
22.
Kempt AmSMLiCKaurHHuangTt. Leptin is a maker of body fat and hyperinsulinemia in college students. J Am Coll Nutr. 2006;55
(3):175–180.
23.
KimMNaWSohnC. Correlation between vitamin D and cardiovascular disease predictors in overweight and obese Koreans. J Clin Biochem Nutr. 2013;52
(2):167–171.
24.
LiuEMeigsJBPittasAG. Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr. 2009;139
(2):329–334.
25.
Al-DaghriNMAl-AttasOSAlokailMS. Hypovitaminosis D associations with adverse metabolic parameters are accentuated in patients with type 2 diabetes mellitus: a body mass index-independent role of adiponectin?J Endocrinol Invest. 2013;36
(1):1–6.
26.
LipsP. Worldwide status of vitamin D nutrition. J Steroid Biochem Mol Biol. 2010;121
(1-2):297–300.
27.
LielYUlmerESharyJHollisBWBellNH. Low circulating vitamin D in obesity. Calcif Tissue Int. 1988;43
(4):199–201.
28.
HyldstrupLAndersenTMcnairPBreumLTransbolI. Bone metabolism in obesity: changes related to severe overweight and dietary weight reduction. Acta Endocrinol (Copenh). 1993;129
(5):393–398.
29.
WortsmanJMatsuokaLYChenTCLuZHolickMF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72
(3):690–693.
IndulekhaKAnjanaRMSurendarJMohanV. Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113). Clin Biochem. 2011;44
(4):281–287.
32.
DingCParameswaranVCicuttiniF. Association between leptin, body composition, sex and knee cartilage morphology in older adults: the Tasmanian older adult cohort (TASOAC) study. Ann Rheum Dis. 2008;67
(9):1254–1256.
33.
MaetaniMMaskarinecGFrankeAACooneyRV. Association of leptin, 25-hydroxyvitamin D, and parathyroid hormone in women. Nutr Cancer. 2009;61
(2):225–231.
34.
AbateNSallamHSRizzoM. Resistin: an inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome [published online December 5, 2013]. Curr Pharm Des. 2013.
35.
RothCLElfersCKratzMHoofnagleAN. Vitamin D deficiency in obese children and its relationship to insulin resistance and adipokines. J Obes. 2011;2011:495101.
36.
OhashiKOuchiNMatsuzawaY. Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie. 2012;94
(10):2137–2142.
37.
SchererPE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes. 2006;55
(6):1537–1545.
38.
NimitphongHChanprasertyothinSJongjaroenprasertWOngphiphadhanakulB. The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance. Endocrine. 2009;36
(2):205–210.
39.
RothCLKratzMRalstonMMReinehrT. Changes in adipose-derived inflammatory cytokines and chemokines after successful lifestyle intervention in obese children. Metabolism. 2011;60
(4):445–452.
40.
VaidyaAWilliamsJSFormanJP. The independent association between 25-hydroxyvitamin D and adiponectin and its relation with BMI in two large cohorts: the NHS and the HPFS. Obesity (Silver Spring). 2012;20
(1):186–191.
41.
KupusinacA SESrdić GalićB. Determination of WHtR limit for predicting hyperglycemia in obese persons by using artificial neural networks. TEM J. 2012;1
(4):270–272.
42.
StokićEKupusinacADoroslovačkiR. Estimating SAD low-limits for the adverse metabolic profile by using artificial neural networks. TEM J. 2013(2):115–119.
